Literature DB >> 16447067

A newborn mouse Cryptosporidium parvum infection model: its application to the study of therapeutic and prophylactic measures for controlling cryptosporidiosis in ruminants.

S Martín-Gómez1, Ma Alvarez-Sánchez, Fa Rojo-Vázquez.   

Abstract

In this study, a newborn mouse model of Cryptosporidium parvum infection is presented so as to evaluate therapeutic and prophylactic measures for controlling cryptosporidiosis in ruminants. Ninety-six suckling mice from ten litters were used. The mice in group I were infected with C. parvum oocysts, and the mice in group II served as non-infected controls. In both groups, intensity of infection and serum IgG, IgA and IgM responses were measured at 6, 9, 12 and 16 days post-infection (pi). Experimentally induced infection in mice proved to be similar to natural infections in lambs, kids and calves. Thus, the intensity of infection peaked at 9 days pi then decreased slightly, showing its lowest value at 16 days pi. This decline in the number of oocysts coincided with peaks in IgM and IgA. Finally, non-infected mice had no oocysts and did not show any increase in their anti-C. parvum antibody levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447067     DOI: 10.1007/s00436-005-0055-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  33 in total

Review 1.  Cryptosporidiosis: laboratory investigations and chemotherapy.

Authors:  S Tzipori
Journal:  Adv Parasitol       Date:  1998       Impact factor: 3.870

2.  Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro.

Authors:  K M Woods; M V Nesterenko; S J Upton
Journal:  Ann Trop Med Parasitol       Date:  1996-12

3.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

Review 4.  Cryptosporidium and cryptosporidiosis in man and animals.

Authors:  P J O'Donoghue
Journal:  Int J Parasitol       Date:  1995-02       Impact factor: 3.981

5.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Age-related resistance in ovine cryptosporidiosis: patterns of infection and humoral immune response.

Authors:  L M Ortegà-Mora; S E Wright
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice.

Authors:  J Heine; H W Moon; D B Woodmansee
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice.

Authors:  G R Finch; C W Daniels; E K Black; F W Schaefer; M Belosevic
Journal:  Appl Environ Microbiol       Date:  1993-11       Impact factor: 4.792

Review 10.  A review of the importance of cryptosporidiosis in farm animals.

Authors:  D C de Graaf; E Vanopdenbosch; L M Ortega-Mora; H Abbassi; J E Peeters
Journal:  Int J Parasitol       Date:  1999-08       Impact factor: 3.981

View more
  3 in total

1.  Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats.

Authors:  Juliette Guitard; Jean Menotti; Allison Desveaux; Parissa Alimardani; Raphaël Porcher; Francis Derouin; Nathalie Kapel
Journal:  Parasitol Res       Date:  2006-04-13       Impact factor: 2.289

2.  Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

Authors:  Autumn S Downey; Curtis R Chong; Thaddeus K Graczyk; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

3.  Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection.

Authors:  Fabio Tosini; Alessandra Ludovisi; Daniele Tonanzi; Marco Amati; Simona Cherchi; Edoardo Pozio; Maria Angeles Gómez-Morales
Journal:  Parasit Vectors       Date:  2019-05-15       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.